Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis.

Hirata Y, Ikeda K, Sudoh M, Tokunaga Y, Suzuki A, Weng L, Ohta M, Tobita Y, Okano K, Ozeki K, Kawasaki K, Tsukuda T, Katsume A, Aoki Y, Umehara T, Sekiguchi S, Toyoda T, Shimotohno K, Soga T, Nishijima M, Taguchi R, Kohara M.

PLoS Pathog. 2012;8(8):e1002860. doi: 10.1371/journal.ppat.1002860. Epub 2012 Aug 16.

2.

A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes.

Katsume A, Tokunaga Y, Hirata Y, Munakata T, Saito M, Hayashi H, Okamoto K, Ohmori Y, Kusanagi I, Fujiwara S, Tsukuda T, Aoki Y, Klumpp K, Tsukiyama-Kohara K, El-Gohary A, Sudoh M, Kohara M.

Gastroenterology. 2013 Oct;145(4):865-73. doi: 10.1053/j.gastro.2013.06.012. Epub 2013 Jun 18.

3.

[Suppression of hepatitis C virus with the reagent targetting host factors].

Hirata Y, Sudoh M, Kohara M.

Uirusu. 2008 Dec;58(2):207-13. Review. Japanese.

4.

Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.

Umehara T, Sudoh M, Yasui F, Matsuda C, Hayashi Y, Chayama K, Kohara M.

Biochem Biophys Res Commun. 2006 Jul 21;346(1):67-73. Epub 2006 May 24.

PMID:
16750511
5.

Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.

Sakamoto H, Okamoto K, Aoki M, Kato H, Katsume A, Ohta A, Tsukuda T, Shimma N, Aoki Y, Arisawa M, Kohara M, Sudoh M.

Nat Chem Biol. 2005 Nov;1(6):333-7. Epub 2005 Oct 16.

PMID:
16408072
6.

[Suppression of hepatitis C virus (HCV) replication with serine palmitoyltransferase inhibitor].

Hirata Y, Sudoh M, Kohara M.

Yakugaku Zasshi. 2010 Feb;130(2):157-61. Review. Japanese.

7.

Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly.

Xu S, Pei R, Guo M, Han Q, Lai J, Wang Y, Wu C, Zhou Y, Lu M, Chen X.

J Virol. 2012 Dec;86(23):13025-37. doi: 10.1128/JVI.01785-12. Epub 2012 Sep 26.

8.

Roles of phosphoinositides and phosphoinositides kinases in hepatitis C virus RNA replication.

Lee C.

Arch Pharm Res. 2012 Oct;35(10):1701-11. doi: 10.1007/s12272-012-1001-2. Epub 2012 Nov 9. Review.

PMID:
23139120
9.

CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.

Rau SJ, Hildt E, Himmelsbach K, Thimme R, Wakita T, Blum HE, Fischer R.

Hepatology. 2013 Jan;57(1):23-36. doi: 10.1002/hep.25966.

PMID:
22814930
10.

New insights into structure and replication of the hepatitis C virus and clinical implications.

Poenisch M, Bartenschlager R.

Semin Liver Dis. 2010 Nov;30(4):333-47. doi: 10.1055/s-0030-1267535. Epub 2010 Oct 19. Review.

PMID:
20960374
11.

c-Fos regulates hepatitis C virus propagation.

Kang SM, Lim S, Won SJ, Shin YJ, Lim YS, Ahn BY, Hwang SB.

FEBS Lett. 2011 Oct 20;585(20):3236-44. doi: 10.1016/j.febslet.2011.08.041. Epub 2011 Sep 8.

12.

Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV).

Aly HH, Oshiumi H, Shime H, Matsumoto M, Wakita T, Shimotohno K, Seya T.

PLoS One. 2011;6(6):e21284. doi: 10.1371/journal.pone.0021284. Epub 2011 Jun 22.

13.

Inducible CYP4F12 enhances Hepatitis C virus infection via association with viral nonstructural protein 5B.

Zhu SL, Wang L, Cao ZY, Wang J, Jing MZ, Xia ZC, Ao F, Ye LB, Liu S, Zhu Y.

Biochem Biophys Res Commun. 2016 Feb 26;471(1):95-102. doi: 10.1016/j.bbrc.2016.01.173. Epub 2016 Feb 1.

PMID:
26845356
14.

Host factors involved in the replication of hepatitis C virus.

Moriishi K, Matsuura Y.

Rev Med Virol. 2007 Sep-Oct;17(5):343-54. Review.

PMID:
17563922
15.

Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein.

Hara H, Aizaki H, Matsuda M, Shinkai-Ouchi F, Inoue Y, Murakami K, Shoji I, Kawakami H, Matsuura Y, Lai MM, Miyamura T, Wakita T, Suzuki T.

J Virol. 2009 May;83(10):5137-47. doi: 10.1128/JVI.02179-08. Epub 2009 Mar 4.

16.

Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+.

Seronello S, Ito C, Wakita T, Choi J.

J Biol Chem. 2010 Jan 8;285(2):845-54. doi: 10.1074/jbc.M109.045740. Epub 2009 Nov 12.

17.

Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA.

Ali Ashfaq U, Ansar M, Sarwar MT, Javed T, Rehman S, Riazuddin S.

Virol J. 2011 Mar 10;8:112. doi: 10.1186/1743-422X-8-112.

18.
19.

Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex.

Moradpour D, Gosert R, Egger D, Penin F, Blum HE, Bienz K.

Antiviral Res. 2003 Oct;60(2):103-9. Review.

PMID:
14638405
20.

[Involvement of nonstructural protein 5A and lipids on production of hepatitis C virus particles].

Suzuki T, Masaki T, Aizaki H.

Uirusu. 2008 Dec;58(2):199-205. Review. Japanese.

Supplemental Content

Support Center